Exiqon has introduced miRcury LNA microRNA family inhibitors.
The inhibitors inactivate all miRNAs within a given miRNA family with a single or few LNA oligos, the company said. Inhibitors are available for all the major human miRNA families.
Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.
Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Wednesday marked the last day of the UBS Global Life Sciences Conference where Affymetrix and Exiqon presented to investors.
Below are highlights from their talks.
Exiqon said this week that it has certified Aros Applied Biotechnology, a genomic services firm based in Aarhus, Denmark, to provide real-time PCR services based on Exiqon’s miRcury LNA Universal RT microRNA PCR product line.